Momentum: MACD histogram is negative (-0.0669) though “negatively contracting,” which can hint selling pressure is easing—but it’s still below zero.
RSI: RSI_6 at ~21 is deeply oversold, increasing odds of a reflex bounce; however, oversold can persist in strong downtrends.
Pattern-based projection: Similar-pattern stats imply only modest upside odds (next day ~0.78%, next week ~2.59%, next month ~7.63%), which is not compelling versus downside risk to S2.
Positive Catalysts
price holding just above S1 (1.
could produce a short-term bounce.
Neutral/Negative Catalysts
Strong bearish trend (moving averages stacked bearishly) and MACD still below zero.
Very weak latest-quarter fundamentals (2025/Q3 revenue at 0; continued losses) reduce confidence in sustained upside.
No supportive news flow in the past week; no clear catalyst to reverse sentiment.
No notable hedge fund/insider trend signals recently (both neutral), and no congress trading data to suggest influential accumulation.
Microcap profile (market cap shown ~$5.16M) often means higher fragility and more erratic price action.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 0, down -100% YoY (collapse in top-line activity).
Net income: -1,657,000, down -20.83% YoY (losses worsened).
EPS: -0.63, down -49.19% YoY.
Gross margin: 0, down -100% YoY.
Overall: Financials show no growth engine and deteriorating profitability trends, which is a major headwind for buying now.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target updates were provided in the data.
Wall Street pros/cons view cannot be validated here due to lack of coverage inputs; based on available fundamentals/technicals, the setup skews negative (downtrend + collapsing revenue) with only a minor oversold-bounce bull case.
Wall Street analysts forecast ABP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABP is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ABP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABP is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
